Showing results (521-530 of 611) with videos related to
Sort By:
Pageof 62
Frontiers in Cardiovascular Medicine|November 3, 2022
SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19Margo Daems, Laurens Liesenborghs, Robbert Boudewijns, et al.Nature|December 13, 2005
Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infectionKoert J Stittelaar, Johan Neyts, Lieve Naesens, et al.Science Translational Medicine|January 24, 2020
Pan-viral protection against arboviruses by activating skin macrophages at the inoculation siteSteven R Bryden, Marieke Pingen, Daniella A Lefteri, et al.Journal of Medicinal Chemistry|November 16, 2019
Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †Sabrina Tassini, Emily Langron, Leen Delang, et al.Cell Host & Microbe|October 12, 2018
A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical TransmissionXuping Xie, Dieudonné B Kum, Hongjie Xia, et al.Nature Communications|December 13, 2025
Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primatesJi Ma, Bert Malengier-Devlies, Babs E Verstrepen, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.Antimicrobial Agents and Chemotherapy|July 13, 2011
Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymeraseI-Hung Shih, Inge Vliegen, Betty Peng, et al.Pageof 62